2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$13.44-$0.03 (-0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $392.3MMarket Cap
- 52.55%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$13.44-$0.03 (-0.22%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.47 | ||
Change | +$0.34 (+2.59%) | ||
Open | $13.27 | ||
High | $13.70 | ||
Low | $13.09 | ||
Previous Close | $13.13 | ||
Volume | 335,246 | ||
30-Day Average Volume | 180,545 | ||
1-Week Change | 2.36% | ||
1-Month Change | 0.37% | ||
1-Year Change | 52.55% | ||
3-Year Change | -15.39% | ||
5-Year Change | -73.75% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $296.9M | ||
Market Cap | $392.3M | ||
Enterprise Value | $358.9M | ||
Period: QTR TTM FY | |||
Revenue | $14.4M | ||
Net Income | -$19.5M | ||
Free Cash Flow | -$10.0M | ||
EBIT | -$15.3M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $149.5M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 4 | ||
P/E | -20 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue